(Q28205423)

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Biological interactions of alpha,beta-unsaturated aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

(E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Human glutathione transferase A4-4: an alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Partial purification and properties of human brain aldehyde dehydrogenases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Deficiency in Mitochondrial Aldehyde Dehydrogenase Increases the Risk for Late-Onset Alzheimer's Disease in the Japanese Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Oxidation and reduction of 4-hydroxyalkenals catalyzed by isozymes of human alcohol dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Structural and kinetic determinants of aldehyde reduction by aldose reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Histological distribution of class III alcohol dehydrogenase in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Microdetermination of aldose and aldehyde reductases from human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

A highly specific aldose reductase inhibitor, ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate, and its congeners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

4-hydroxy-2,3-trans-nonenal induces transcription and expression of aldose reductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Purification and characterization of human-brain aldose reductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Macrophages/microglial cells in human central nervous system during development: an immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Oxidative stress hypothesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Decreased base excision repair and increased helicase activity in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686

S-methylation as a bioactivation mechanism for mono- and dithiocarbamate pesticides as aldehyde dehydrogenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.7.686